Fig. 4: RAD51B-deficiency and sensitivity to MMC and PARPi.

A, B Clonogenic survival assays of the indicated cell lines in response to olaparib or mitomycin C. Cells were expressing one of two independent RAD51B shRNAs, Renilla shRNA (nontarget control), or BRCA1 shRNA (positive control). Error bars represent SEM.